← back to search

Evette S. Radisky

Sylvester Comprehensive Cancer Center ·
Area of research
Cancer Research · Oncology
Research interest
Research focused on Matrix metalloproteinase and Computational biology, with related work in Cancer, Matrix metalloproteinase inhibitor, Serine protease. Notable publications include 'Development of High Affinity and High Specificity Inhibitors of Matrix Metalloproteinase 14 through Computational Design and Directed Evolution', 'Long-range Electrostatic Complementarity Governs Substrate Recognition by Human Chymotrypsin C, a Key Regulator of Digestive Enzyme Activation', and 'Converting a broad matrix metalloproteinase family inhibitor into a specific inhibitor of MMP ‐9 and MMP ‐14'.
h-index
citations
360
works
12
NIH funding
primary concept
email

Recent publications

Engineered TIMP2 with narrow MMP-9 specificity is an effective inhibitor of invasion and proliferation of triple-negative breast cancer cells
Journal of Biological Chemistry 2024cited by 10position: middledoi
Improving Circulation Half-Life of Therapeutic Candidate N-TIMP2 by Unfolded Peptide Extension
Biomolecules 2024cited by 5position: middledoi
Abstract 1331 Engineering Tissue Inhibitor of Metalloproteinases-1 (TIMP-1) Variants with Improved Binding Selectivity toward Matrix Metalloproteinase-9 (MMP-9) as potential protein therapeutics
Journal of Biological Chemistry 2024cited by 1position: lastdoi
The roles of proteases in prostate cancer
IUBMB Life 2023cited by 35position: middledoi
Designed Loop Extension Followed by Combinatorial Screening Confers High Specificity to a Broad Matrix MetalloproteinaseInhibitor
Journal of Molecular Biology 2023cited by 16position: middledoi
Climbing Up and Down Binding Landscapes through Deep Mutational Scanning of Three Homologous Protein–Protein Complexes
Journal of the American Chemical Society 2021cited by 35position: middledoi
Converting a broad matrix metalloproteinase family inhibitor into a specific inhibitor of <scp>MMP</scp> ‐9 and <scp>MMP</scp> ‐14
FEBS Letters 2018cited by 47position: middledoi
A potent, proteolysis-resistant inhibitor of kallikrein-related peptidase 6 (KLK6) for cancer therapy, developed by combinatorial engineering
Journal of Biological Chemistry 2018cited by 33position: middledoi
Development of High Affinity and High Specificity Inhibitors of Matrix Metalloproteinase 14 through Computational Design and Directed Evolution
Journal of Biological Chemistry 2017cited by 81position: middledoi
Serine protease inhibitor Kazal type 1 (SPINK1) drives proliferation and anoikis resistance in a subset of ovarian cancers
Oncotarget 2015cited by 35position: lastdoi
Zymogen Activation Confers Thermodynamic Stability on a Key Peptide Bond and Protects Human Cationic Trypsin from Degradation
Journal of Biological Chemistry 2014cited by 13position: middledoi
Long-range Electrostatic Complementarity Governs Substrate Recognition by Human Chymotrypsin C, a Key Regulator of Digestive Enzyme Activation
Journal of Biological Chemistry 2013cited by 49position: lastdoi

Grants

No grants ingested yet.

Frequent collaborators

Julia M. Shifman · Hebrew University of Jerusalem6 papers (2017–2024)Alexandra Hockla · Sylvester Comprehensive Cancer Center6 papers (2015–2024)Jason Shirian · Hebrew University of Jerusalem5 papers (2017–2024)Itay Cohen · Hebrew University of Jerusalem4 papers (2017–2021) · 4 papers (2017–2021)Miklós Sahin‐Tóth · U.S. National Science Foundation3 papers (2013–2015)John A. Copland · Southwestern Medical Center2 papers (2015–2024)Naama Rotenberg · Hebrew University of Jerusalem2 papers (2024–2024)András Szabó · University of Debrecen2 papers (2013–2014)Matt Coban · Sylvester Comprehensive Cancer Center2 papers (2024–2024) · 2 papers (2017–2018) · 1 papers (2018–2018)Aylin Alasonyalılar Demirer · Sylvester Comprehensive Cancer Center1 papers (2024–2024)Krista M. Goergen · Roswell Park Comprehensive Cancer Center1 papers (2015–2015)Mark Feldman · Hebrew University of Jerusalem1 papers (2024–2024)Antoine Dufour · Alberta Children's Hospital Research Institute1 papers (2023–2023)Laura M. Strik · Sylvester Comprehensive Cancer Center1 papers (2024–2024)Gary L. Keeney · Mayo Clinic in Arizona1 papers (2015–2015)Matt L. Pawlush · Sylvester Comprehensive Cancer Center1 papers (2024–2024)John D. Hooper · University of Queensland1 papers (2023–2023)